Methods for inducing an immune response with an elevated th1/th2 ratio, by intracellular induction of nfkappab
CA 2451479 A1 · Owner: Foxwell, Brian Maurice John · Inventors: Foxwell, Brian Maurice John; Feldmann, Marc
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method of increasing the TH1:TH2 ratio of an immune response, comprising the step of supplying to an antigen presenting cell (APC) such as a dendritic cell (DC) or precursor cell an intracellular , activator of A-PC, such as DC function. The invention also provides a method of treating a patient with or at risk of allergy comprising the step of supplying an intracellular activator of A-PC such as DC, function, or an , intracellular inducer of NF.kappa.B to the patient or to an APC, such as a DC, or precursor cell, of the patient.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 5, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 5, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 5, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.